Navigation Links
US Peptides Updates Website with New Information
Date:11/12/2013

TAMPA, Fla., Nov. 12, 2013 /PRNewswire-iReach/ -- US Peptides, a leading supplier of research peptides in the United States has changed the layout of the site and improved content for better user experience at http://uspeptides.com/.

(Photo: http://photos.prnewswire.com/prnh/20131112/MN14448)

The redesigned website features an easy to use menu to quickly and efficiently locate product as well as user friendly articles which are based on past studies and research regarding the very same research peptides available on the web site.

As an example of content the article titled "What IGF-1 Does in the Body" (located here http://uspeptides.com/articles/what-igf-1-does-in-the-body/  ) goes on to explain what the IGF-1 peptide does from ingestion on. For those that do not recall, there was a former Super Bowl winning middle linebacker that had some rumors surrounding him based on some accusations that he may have used this type of product to improve healing and/or increase performance on the field.

US Peptides views this web site as a step towards developing an impressive online presence and they plan on continuing to build upon this solid foundation in the future.

In an effort to celebrate the new redesign and focus on a fast, efficient, quality site US Peptides is giving a 10% discount on all orders with 10 items or more in the shopping cart. There is no need to add a coupon or special code, this discount is applied automatically at checkout.

About US Peptides, LLC

US Peptides, LLC founded in 2010 to work with researchers doing studies and clinical trials with peptides. In addition to CJC-1295 research peptide, US Peptides also provides researchers with other much in demand peptides including GHRP, Melanotan, Semorelin, IGF-LR3, Growth Factor, GHRP 2, Hexarelin, MGF, MGF Ipamorelin, Mechano Growth Factor, and IGF. Disclaimer: All products listed and provided through USPeptides.com are intended for research purposes only. We do not promote the personal use of these products. Products provided by USPeptides.com are not intended for use in food products or as any type of drug. Our products are not intended to treat, prevent, mitigate or cure any disease or medical condition and are for research purposes only.

Media Contact: Don Pierce, US Peptides LLC, 727-210-7821, info@useptides.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE US Peptides LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. US Peptides Discusses HGH and Growth Hormone Releasing Peptides and How They Affect Performance
2. Arg-Phe-amide-related peptides influence gonadotropin-releasing hormone neurons
3. Updates in Interventional Radiology accents emerging trends, practice growth
4. NREL updates solar radiation database
5. Biometrics Market Research Updates From Global Information
6. Neurotechnology Announces MegaMatcher Accelerator 6.0 High-speed, High-volume Multibiometric Identification Solution and Updates to Entire Biometric Product Line
7. Accelrys Hosts Analyst Day, Updates Calendar Year 2013 Outlook
8. NIST launches new website to educate industry about alternatives to mercury thermometers
9. Revealing climate change website wins global award
10. Website for new open-access journal, eLife, introduced today
11. The Website You Have to Log Into
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis zum Jahr 2018 ... mehr als 50 Vertretern aus verschiedenen Branchen wurde aber klar, ... Prognose zu realisieren. ... Zu den Schwierigkeiten für Biobanking-Profis ... die Biobank, die Implementierung Zeit sparender Technologien, ein besseres ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... 2017 The biometrics market has reached ... of organizations, desires to better authenticate or identify ... and challenge questions), biometrics is quickly working its ... market is driven by use cases, though there ... enterprise uses cases, with consumer-facing use cases encompassing ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... 27, 2017 Four US Biotech ... today, and they are: Anthera Pharmaceuticals Inc. (NASDAQ: ANTH), ... Inc. (NASDAQ: PACB), and Conatus Pharmaceuticals Inc. (NASDAQ: ... Trends, market observers are growing more bullish on the ... reforms to free cash held overseas for tax reason ...
(Date:2/27/2017)... , ... February 27, 2017 , ... The Catalyst ... a few in the Midwest offering premix services and private label organic services. , ... laying hens, according Jos Zamzow, chief operating officer of Dynamite Marketing, which owns the ...
(Date:2/24/2017)... ... ... Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, today announced ... for the further advancement of the company’s 3-month olanzapine product ( DLP-119 ). The ... therapeutic levels of olanzapine for a period of 3 months., “We are honored and ...
(Date:2/24/2017)... SAN FRANCISCO , Feb. 24, 2017 ... that is developing a new category of therapeutics, announced ... trial of SB-030 in peripheral artery disease. The trial ... locally administered single-use therapeutic, in the reduction of restenosis ... reached this critical development milestone for SB-030," said ...
Breaking Biology Technology: